✦ LIBER ✦

PCN26 A COST-EFFECTIVENESS ANALYSIS OF XELOX AND FOLFOX-4 COMBINED WITH OR WITHOUT BEVACIZUMAB FOR THE TREATMENT OF METASTATIC COLORECTAL CANCER IN SPAIN

✍ Scribed by J Darba; G Restovic; A Ramírez de Arellano

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN87 PHARMACOECONOMIC ANALYSIS OF DIREC

✍ A Tikhomirova; A Kulikov; R Yagudina 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

Cost-effectiveness analysis of bevacizum

✍ Takeru Shiroiwa; Takashi Fukuda; Kiichiro Tsutani 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 238 KB

PCN110 COST-MINIMIZATION ANALYSIS OF XEL

✍ AS Zazaa; H AlOmar; SA El-Moursy; M AlFayyadh 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

PCN42 A SENSITIVITY ANALYSIS ON THE COST

✍ P Ducournau; G Lewis; A McDonald; DR Millar; E Sabate; S Walzer 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

PCN70 Cost-Effectiveness of Cetuximab an

✍ Samyshkin, Y.; Hertel, N.; Griebsch, I. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PCN70 MODELLING THE COST EFFECTIVENESS O

✍ C Holmberg; R Aultman; U Siebert; E Sabate; M Gyldmark 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB